BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2464098)

  • 1. Dihydropyridine binding sites in aerobically perfused, ischemic, and reperfused rat hearts: effect of temperature and time.
    Gu XH; Dillon JS; Nayler WG
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):272-8. PubMed ID: 2464098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection by verapamil and nifedipine against ischaemia-induced loss of [3H]-(+)-PN 200-110 binding sites in the rat heart.
    van Amsterdam FT; van Amsterdam-Magnoni MS; Haas M; Punt NC; Zaagsma J
    Naunyn Schmiedebergs Arch Pharmacol; 1990; 341(1-2):137-42. PubMed ID: 2156175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
    Lee HR; Roeske WR; Yamamura HI
    Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
    Zheng W; Hawthorn M; Triggle DJ
    Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
    Wei XY; Rutledge A; Triggle DJ
    Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of hypoxia and of energy depletion on 1,4-dihydropyridine binding sites in rat cardiac membrane fragments.
    Gu XH; Dillon JS; Nayler WG
    Biochem Pharmacol; 1989 Jun; 38(12):1897-907. PubMed ID: 2742598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effect of ischemia on myocardial dihydropyridine binding sites.
    Nayler WG; Dillon JS; Elz JS; McKelvie M
    Eur J Pharmacol; 1985 Sep; 115(1):81-9. PubMed ID: 2412860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of (+)-PN 200-110 to rat pituitaries and to normal and adenomatous human pituitaries.
    Bression D; Chaumet-Riffaud P; Brandi AM; Comte A; Peillon F; Kiechel JR
    Mol Cell Endocrinol; 1987 Apr; 50(3):255-61. PubMed ID: 3032711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of propionyl-L-carnitine on L-type calcium channels in human heart sarcolemma.
    Bevilacqua M; Vago T; Norbiato G
    Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():31-5. PubMed ID: 1851633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydropyridine receptor binding sites in the cardiomyopathic hamster heart are unchanged from control.
    Bazan E; Sole MJ; Schwartz A; Johnson CL
    J Mol Cell Cardiol; 1991 Feb; 23(2):111-7. PubMed ID: 1648625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischemia and reperfusion increase 125I-labeled endothelin-1 binding in rat cardiac membranes.
    Liu J; Chen R; Casley DJ; Nayler WG
    Am J Physiol; 1990 Mar; 258(3 Pt 2):H829-35. PubMed ID: 2180323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium channel receptor sites for (+)-[3H]PN 200-110 in coronary artery.
    Yamada S; Kimura R; Harada Y; Nakayama K
    J Pharmacol Exp Ther; 1990 Jan; 252(1):327-32. PubMed ID: 2153804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Halothane modifies ischemia-associated injury to the voltage-sensitive calcium channels in canine heart sarcolemma.
    Drenger B; Ginosar Y; Chandra M; Reches A; Gozal Y
    Anesthesiology; 1994 Jul; 81(1):221-8. PubMed ID: 8042789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonist binding sites in failing and nonfailing human ventricular myocardium.
    Rasmussen RP; Minobe W; Bristow MR
    Biochem Pharmacol; 1990 Feb; 39(4):691-6. PubMed ID: 2154992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The failure of endothelin to displace bound, radioactively-labelled, calcium antagonists (PN 200/110, D888 and diltiazem).
    Gu XH; Liu JJ; Dillon JS; Nayler WG
    Br J Pharmacol; 1989 Feb; 96(2):262-4. PubMed ID: 2538185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1 adrenoceptors in the ischaemic and reperfused myocardium.
    Dillon JS; Gu XH; Nayler WG
    J Mol Cell Cardiol; 1988 Aug; 20(8):725-35. PubMed ID: 2851664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of 1,4, dihydropyridine calcium channel binding sites in the human prostate.
    Rosenthal E; Shapiro E; Lepor H
    J Urol; 1990 Dec; 144(6):1539-42. PubMed ID: 1700163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC; Ptasienski J; Hosey MM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]-verapamil binding to rat cardiac sarcolemmal membrane fragments; an effect of ischaemia.
    Dillon JS; Nayler WG
    Br J Pharmacol; 1987 Jan; 90(1):99-109. PubMed ID: 3028561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depolarization of chick myotubes triggers the appearance of (+)-[3H]PN 200-110-binding sites.
    Pauwels PJ; Van Assouw HP; Leysen JE
    Mol Pharmacol; 1987 Dec; 32(6):785-91. PubMed ID: 2826992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.